Back to search

Peptide record

TPDB26358

Antibacterial Anticancer Toxicity modified_plain modified
19 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB26358
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia
modified_plain
Yes
A 19-aa modified multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia, with an available 3D structural model.
Modified, details unspecified
Sequence
VXKPPYLPRPRWPRXIYNX
Physicochemical Analysis
C99H150N28O20
ADCEQGHMFST
P
2052.46
11.35
4
0
6
+4
1.56
-1.047
56.32
Mammalian: 100 hour Yeast: >20 hour E.coli: >10 hour
8480
413.16
3
Residue Composition
number
0
A
3
R
1
N
0
D
0
C
0
E
0
Q
0
G
0
H
1
I
1
L
1
K
0
M
0
F
5
P
0
S
0
T
1
W
2
Y
1
V
Amino Acid Distribution
A: 0 R: 3 N: 1 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 1 K: 1 M: 0 F: 0 P: 5 S: 0 T: 0 W: 1 Y: 2 V: 1
Chemical Descriptors
19
C99H150N28O20
2052.46
11.35
+4
1.56
-1.047
Evidence Records 2 records
Evidence 1 Activity

Activity

Toxicity
Cytotoxic
- | NA | target cell: Human embryonic kidney HEK293 cells

Target

Human embryonic kidney HEK293 cells

Source & Reference

NA
DBAASP
Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus. | Amino Acids | 2016
Evidence 2 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: HEK293: Not active up to 600 µg/ml

Target

erythrocytes

Source & Reference

NA
DRAMP
Amino Acids. 2016 Jan 48(1):269-80.